Correlation Between Foghorn Therapeutics and Biohaven Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Foghorn Therapeutics and Biohaven Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Foghorn Therapeutics and Biohaven Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Foghorn Therapeutics and Biohaven Pharmaceutical Holding, you can compare the effects of market volatilities on Foghorn Therapeutics and Biohaven Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Foghorn Therapeutics with a short position of Biohaven Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Foghorn Therapeutics and Biohaven Pharmaceutical.
Diversification Opportunities for Foghorn Therapeutics and Biohaven Pharmaceutical
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Foghorn and Biohaven is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Foghorn Therapeutics and Biohaven Pharmaceutical Holdin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biohaven Pharmaceutical and Foghorn Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Foghorn Therapeutics are associated (or correlated) with Biohaven Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biohaven Pharmaceutical has no effect on the direction of Foghorn Therapeutics i.e., Foghorn Therapeutics and Biohaven Pharmaceutical go up and down completely randomly.
Pair Corralation between Foghorn Therapeutics and Biohaven Pharmaceutical
Given the investment horizon of 90 days Foghorn Therapeutics is expected to generate 1.34 times more return on investment than Biohaven Pharmaceutical. However, Foghorn Therapeutics is 1.34 times more volatile than Biohaven Pharmaceutical Holding. It trades about 0.07 of its potential returns per unit of risk. Biohaven Pharmaceutical Holding is currently generating about -0.11 per unit of risk. If you would invest 762.00 in Foghorn Therapeutics on September 1, 2024 and sell it today you would earn a total of 37.00 from holding Foghorn Therapeutics or generate 4.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Foghorn Therapeutics vs. Biohaven Pharmaceutical Holdin
Performance |
| Timeline |
| Foghorn Therapeutics |
| Biohaven Pharmaceutical |
Foghorn Therapeutics and Biohaven Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Foghorn Therapeutics and Biohaven Pharmaceutical
The main advantage of trading using opposite Foghorn Therapeutics and Biohaven Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Foghorn Therapeutics position performs unexpectedly, Biohaven Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biohaven Pharmaceutical will offset losses from the drop in Biohaven Pharmaceutical's long position.| Foghorn Therapeutics vs. C4 Therapeutics | Foghorn Therapeutics vs. Prelude Therapeutics | Foghorn Therapeutics vs. Rezolute | Foghorn Therapeutics vs. Shattuck Labs |
| Biohaven Pharmaceutical vs. Immunome | Biohaven Pharmaceutical vs. Inhibrx | Biohaven Pharmaceutical vs. Day One Biopharmaceuticals | Biohaven Pharmaceutical vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |